BERKELEY, Calif. The Food and Drug Administration and the European Medicines Agency have given license approval to Bayer HealthCare for a new sterile filling facility on its Berkeley, Calif., campus, the company said Monday.
Bayer said the licenses from the FDA and EMEA will allow it to support the supply of its Kogenate line of products in the United States and European Union.
